Qingbo Sui, DO
Family Medicine · San Jose
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- 3
- 2 carriers
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plans that list them
3 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sui’s office at (408) 573-9866 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
3 of 3 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
Medicaid work
$139,735 in 2020
Medicaid paid $139,735 for 1,904 billed services this clinician did in 2020, up to 158 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 717 | $138,011 |
| Short return visit (20+ min) | 1,059 | $1,500 |
| New patient visit (30+ min) | 41 | $212 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 39 | $12 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 12 | $0 |
| Short return visit | 36 | $0 |
| 2020 | 1,904 | 6 | 158 | $139,735 |
| 2019 | 4,021 | 19 | 189 | $215,305 |
| 2018 | 5,618 | 24 | 204 | $358,915 |
See the largest Medicaid services in earlier years
2019
| Clinic visit/encounter, all-inclusive | 1,362 | $189,474 |
| Short return visit (20+ min) | 1,049 | $9,644 |
| Short return visit | 659 | $7,485 |
| Screening test, pure tone, air only | 112 | $2,176 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 25 | $1,870 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 201 | $1,770 |
| Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use | 31 | $558 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 15 | $548 |
| Bilateral quantitative screening test of visual acuity | 86 | $502 |
| New patient visit (30+ min) | 41 | $411 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 86 | $321 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Influenza | 28 | $284 |
2018
| Clinic visit/encounter, all-inclusive | 2,338 | $278,455 |
| Short return visit | 821 | $16,449 |
| Short return visit (20+ min) | 676 | $15,357 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 116 | $10,121 |
| Screening test, pure tone, air only | 380 | $7,800 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 92 | $6,805 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 46 | $5,044 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 46 | $3,122 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years | 14 | $2,367 |
| Bilateral quantitative screening test of visual acuity | 352 | $2,168 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 118 | $2,124 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 107 | $2,096 |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 285 Part D prescriptions in 2020.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2020 | 285 | 103 | 0% (0) | None | $11,022 |
| 2019 | 329 | 100 | 0% (0) | 14% | $16,702 |
| 2018 | 261 | 59 | None | None | $13,013 |
| 2017 | 69 | 28 | 0% (0) | None | $4,167 |
| 2016 | 37 | 19 | 0% (0) | None | $1,579 |
| 2015 | 15 | None | 0% (0) | None | $192 |
| 2014 | 29 | 17 | 0% (0) | None | $4,664 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2020: 7 drugs
| Atorvastatin | 25 | $335 | $13 |
| Fluticasone Propionate | 13 | $297 | $23 |
| Amlodipine Besylate | 29 | $202 | $7 |
| Lisinopril | 17 | $76 | $4 |
| Metformin | 11 | $70 | $6 |
| Omeprazole | 11 | $42 | $4 |
| Ibuprofen | 12 | $37 | $3 |
2019: 10 drugs
| Januvia | 15 | $5,617 | $374 |
| Lisinopril | 28 | $179 | $6 |
| Fluticasone Propionate | 11 | $177 | $16 |
| Omeprazole | 15 | $124 | $8 |
| Simvastatin | 11 | $98 | $9 |
| Amlodipine Besylate | 21 | $94 | $4 |
| Metformin | 14 | $76 | $5 |
| Hydrochlorothiazide | 17 | $58 | $3 |
| Glimepiride | 13 | $39 | $3 |
| Ranitidine | 11 | $22 | $2 |
2018: 4 drugs
| Levothyroxine | 12 | $124 | $10 |
| Omeprazole | 12 | $64 | $5 |
| Lisinopril | 11 | $60 | $5 |
| Hydrochlorothiazide | 18 | $30 | $2 |
Money from drug and device companies
$115 in 2019
A payment is not proof that care is biased.
See all 2 published payments
| Celgene | Meals · 2019-01-29 | Otezla | $65 |
| Ucb | Meals · 2019-01-28 | Cimzia | $50 |
Professional record
- NPI
- 1679996151
- Licence
- CA 20A15294
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X); Student in a training program (390200000X)
- Mailing address
- 1520 Stockton Street, San Francisco, CA, 94133
- NPI first listed
- 2014-02-04
- NPI last updated
- 2019-07-31
This is when the NPI record was last certified, not a medical board exam.